Welcome
Friday, September 03, 2010
Friday, September 03, 2010
Latest Procurement News
Posted: Wednesday, October 28, 2009, 9:33AM
RELATED NEWS
- Microsoft adopts cloud-based SRM
02 Sep 10 - Nestlé optimises coffee supply chain
31 Aug 10 - MIQ Logistics names new chairman and CEO
27 Aug 10 - Singapore crowned world's largest container port
26 Aug 10 - Halfords suffers supply chain delays
26 Aug 10 - Supply chain overhaul key to GM IPO
23 Aug 10
RELATED ARTICLES
- Profile: Siemens CPO, Barbara Kux
- In Focus: Top companies turn spotlight on effective supply chain operations
- In Focus: Bank of England sparks debate on supply chain finance
- Agility key to competitive supply chains
- ITV CPO on transforming procurement in a difficult market
- Economic view: Trade policies pose new challenges in an upturn
KNOWLEDGE MANAGEMENT TAGS
"Supply Chain Management"
US supply chain blitz targets counterfeit drugs
Substandard and counterfeit versions of medicines are threatening the lives of thousands of people throughout the developing world suffering from diseases including malaria, HIV/AIDS and tuberculosis, the US Agency for International Development (USAID) and the US Pharmacopeial (USP) Convention warn. To combat this growing threat the organisations vowed to expand their joint efforts by launching a new programme over the next five years.
The Promoting the Quality of Medicines (PQM) Program, a $35m cooperative agreement, will serve as a primary mechanism to help assure the quality, safety and efficacy of medicines that are essential to USAID's priority health programmes.
"The lives of patients are put in serious jeopardy when they take substandard or counterfeit drugs," said Roger L. Williams, M.D., chief executive officer of USP. "Such 'medicines' have health as well as economic implications. Moreover, substandard medicines contribute to the development of drug-resistant strains of infectious diseases. Such strains are a leading challenge in the fight against malaria, HIV/AIDS and tuberculosis."
The programme aims to help ensure the quality, safety and efficacy of medicines by: working with countries to strengthen their medicines regulatory bodies; increasing the supply of good-quality medicines; combating the availability of counterfeit and substandard medicines and conducting global advocacy to raise awareness of the dangers of substandard and counterfeit drugs.
"Substandard and counterfeit medicines represent a threat to public health worldwide but pose a particular problem in developing countries, where lack of financial, technical and other resources make it difficult to protect the drug supply chains," said Gloria Steele, USAID acting assistant administrator for Global Health.
"Such medicines undermine decades of investments in public health. Without good quality, safe medicines to treat diseases such as malaria and tuberculosis, the impact of other health initiatives is severely weakened if not negated completely. The PQM Program focuses on this critical aspect of combating these diseases."
USAID is a US government agency that provides economic, development and humanitarian assistance around the world in support of the foreign policy goals of the United States. USP is a nonprofit scientific organisation that develops globally recognised standards for the quality of medicines.
Procurement Tags - Supply Chain Management, U.S.
= Associate Members Only 
